Maynard Um
-
-
-
-
-
-
-
RBC Capital on Boston Scientific (BSX): 'Lower WATCHMAN Outlook Drives Stock Down 13% Today'
-
-
-
-
-
-
-
Truist Securities Reiterates Buy Rating on Boston Scientific (BSX) amid buyback and third TAVR attempt
-
-
-
-
-
-
-
Boston Scientific (BSX) PT Lowered to $84 at Goldman Sachs
-
-
-
-
-
-
-
Boston Scientific (BSX) call put ratio 1.5 calls to 1 put as share price down 1.9%
-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Boston Scientific (BSX)
-
-
-
-
-
-
-
Raymond James Downgrades Boston Scientific (BSX) to Outperform
-
-
-
-
-
-
-
Piper Sandler: 'When Will Things Turn in Med Tech and What Names to Own Now?'
-
397,102 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

